Related by context. Frequent words. (Click for all words.) 66 Randomized controlled 62 Pivotal Phase III 61 Initiate Phase 60 Visit http:/www.Comtex.com 59 #mg/day [001] 59 MKC# 59 placebo controlled clinical 58 ongoing Phase 1b 58 Pivotal Phase 58 Epanova 58 Initiates Phase II 58 pharmacodynamic effects 58 phase IIa clinical 58 Acute Myocardial Infarction 58 Phase Ib clinical 58 refractory chronic lymphocytic 57 Cloretazine R VNP#M 57 Zoraxel 57 pharmacokinetics PK 57 II Clinical Trial 57 plus prednisone 57 teriflunomide 56 phase IIb clinical 56 Phase Ib II 56 multicenter clinical 56 Phase 1b clinical 56 Phase 2a clinical 56 double blinded placebo 56 KRN# 56 Pharmacokinetic 56 HGS ETR2 56 Dapagliflozin 56 prospective randomized controlled 56 Antihypertensive 56 Completes Enrollment 56 Phase 1b trial 55 forodesine 55 Phase IIIb 55 Phase III Clinical Trial 55 Phase Ia 55 randomized controlled clinical 55 PSN# [002] 55 Commences Phase 55 ataluren 55 relapsed refractory multiple myeloma 55 Heart Failure Patients 55 Improves Survival 55 irbesartan 55 blinded placebo controlled 55 relapsing multiple sclerosis 55 Initiates Phase 55 multicenter randomized 55 R sorafenib tablets 54 Serada 54 multicenter prospective 54 analgesic efficacy 54 HALTS 54 nab paclitaxel 54 metastatic castration resistant 54 pharmacokinetic parameters 54 Metastatic Melanoma 54 EVEREST II 54 phase IIa 54 IIa trial 54 Monotherapy 54 phase Ib 54 Pivotal Trial 54 Chronic Hepatitis C 54 active comparator 54 Daclizumab 54 HGS ETR1 54 multicenter Phase 54 Renal Cell Carcinoma 54 prospective multicenter 54 Engerix B 53 olmesartan 53 metreleptin 53 Metastatic Colorectal Cancer 53 Prostate Cancer Prevention 53 Pivotal Study 53 metastatic hormone refractory 53 placebo controlled randomized 53 Phase III Trial 53 Presents Positive 53 TRITON TIMI 53 randomized multicenter 53 Chronic Heart Failure 53 Multicenter 53 pertuzumab 53 blind randomized controlled 53 Aliskiren 53 Phase IIb clinical 53 EDEMA4 53 placebo controlled Phase 52 QLT# 52 fluvastatin 52 pseudobulbar affect PBA 52 liposomal formulation 52 OncoVEX GM CSF 52 randomized Phase III 52 TOLAMBA